INNOHEP 3500 IU/10 SYRINGE 0.35ML

INNOHEP 3500 IU/10 SYRINGE 0.35ML
Innohep Ser Sc 10 X 3500 Iu 0,35ml
By prescriptionYesPrescriptionDownload leafletUsePrevention50 IU anti-Xa/kg body weight, 2 hours before surgeryThen 1x /24 h until the patient is ambulatory or for 7 to 10 days50 IU anti-Xa/kg body weight, 2 hours before surgeryThen 1x /24 h until the patient is ambulatory or for 7 - 10 days1 fixed dose of 4,500 IU anti-Xa, 12 hours before the orthopedic procedureThen 1x /24hTherapy175 IU anti-Xa/kg body weight 1x/dayMethod of administrationsubcutaneousThe site www.thrombosiscare.be contains a video to explain the auto-injection to the patientThe recommended site for injection is in the lower abdomen fatThe injection should be done at least 5 cm next to the navel and out to one side or the otherChoose a different site of the lower abdomen for each injection, alternating between the left and right sidesSit or lie down in a comfortable position and clean the chosen injection site with an alcohol swabTake the syringe and remove the protective capDo not remove the air bubble from the syringeAny drop at the tip of the needle can be removed by tapping the syringe with the needle pointing downwardsTake a fold of skin between your thumb and forefingerInsert the needle fully and perpendicularly into the thickest part of the pleatGently push the plunger of the syringe ; the injection must be done slowlyHold the fold of skin until the injection is finishedDo not massage or press the skin after the injectionUse in hemodialysis: see package leafletApplicationThrombosis and ThromboembolismProphylactic treatment ofthromboembolic events of venous origin in general and orthopedic surgery in adultsPrevention of Blood Clots in Ingoing Intravenous Blood Lines in Extracorporeal Circulation and Hemodialysis in AdultsTreatment ofvenous thrombosis and of thromboembolic disorders in adults including deep vein thrombosisof patients with moderate pulmonary embolism who are not eligible for thrombolysis, embolectomy and/or vena cava filterThe site www.thrombosiscare.be contains patient information about the signs and symptoms associated with a venous thrombosis as well as explanations by means of illustrations
Innohep 3500 UI
Solución inyectable en jeringa precargada
Medicamento en forma farmaceútica de tipo solución inyectable en jeringa precargada, se administra por vía intravenosa, compuesto por 10.000 UI del principio activo Tinzaparina sodica. Contiene los excipientes Acetato de sodio trihidrato (5mg), Hidroxido de sodio (E-524) (----CSP PH).
Innohep 3500 Iu Anti-Xa / 0.35 Ml - 10 Syringes
A valid prescription needed upon order collection
TRADE NAME
Innohep 10000 Anti-Xa Iu-Ml Syring
 
SCIENTIFIC NAME
Tinzaparin Sodium
 
PRODUCT TYPE
Human
 
DRUG TYPE
Biological
 
PHARMACEUTICAL FORM
Injection, Solution
 
ADMINISTRATION ROUTE
Subcutaneous
 
PACKAGE TYPES
Pre-filled syringe
 
LEGAL STATUS
Prescription
 
STORAGE CONDITIONS
do not store above 30°c
 
COMPANY
Leo Pharma
 
REGISTER YEAR
2002